Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pancreatic Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Glioma 1Glioblastoma 1Ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 4Surgical Procedures, Operative 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Gadolinium DTPA 2Filgrastim 2Erlotinib Hydrochloride 2Congresses as Topic 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vitespin 1sargramostim 1picropodophyllin 1marizomib 1imetelstat 1gadobutrol 1gadobenic acid 1fluorodopa F 18 1bempegaldesleukin 1antineoplaston AS 2-1 1antineoplaston A10 1Yoga 1Transurethral Resection of Bladder 1Topotecan 1Thiotepa 1Ritonavir 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Perfusion Magnetic Resonance Imaging 1O(6)-benzylguanine 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Ependymoma × Transurethral Resection of Bladder × Clear all
NCT02722512 2025-02-18

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Terminated
10 enrolled
CNS

Astrocytoma, Ependymoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡